Lead Sponsor

Gilead Sciences

Age

All ages

Sex

ALL

Healthy Volunteers

No

•Completion of a prior EVG+RTV treatment study without treatment-limiting toxicity.
•Males and females of childbearing potential must agree to utilize effective contraception methods.
•Ability to understand and sign a written informed consent form.

•Females who are pregnant or breastfeeding.
•Participation in any other clinical trial without prior approval from the Sponsor.
•Any other clinical condition or prior therapy that, in the opinion of the investigator, would make the subject unsuitable for the study.
•Subjects receiving ongoing therapy with contraindicated drugs.